Snow Capital Management’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-11,816
Closed -$816K 140
2021
Q1
$816K Sell
11,816
-13,792
-54% -$934K 0.12% 101
2020
Q4
$1.66M Sell
25,608
-2,000
-7% -$108K 0.28% 78
2020
Q3
$1.3M Buy
27,608
+6,875
+33% +$327K 0.26% 84
2020
Q2
$974K Hold
20,733
0.2% 96
2020
Q1
$926K Buy
+20,733
New +$1.09M 0.21% 92
2017
Q1
Sell
-132,140
Closed -$5.67M 137
2016
Q4
$5.67M Sell
132,140
-161,720
-55% -$6.57M 0.26% 65
2016
Q3
$12.1M Sell
293,860
-54,950
-16% -$2.3M 0.55% 42
2016
Q2
$13.9M Sell
348,810
-85,440
-20% -$3.07M 0.65% 40
2016
Q1
$14.6M Sell
434,250
-163,844
-27% -$5.1M 0.64% 41
2015
Q4
$20.3M Buy
598,094
+38,050
+7% +$1.19M 0.81% 35
2015
Q3
$16.7M Sell
560,044
-102,192
-15% -$3.2M 0.6% 46
2015
Q2
$18.2M Buy
662,236
+220,697
+50% +$5.88M 0.53% 43
2015
Q1
$11.1M Sell
441,539
-27,817
-6% -$658K 0.35% 51
2014
Q4
$10.4M Buy
469,356
+213,051
+83% +$4.32M 0.31% 51
2014
Q3
$5.2M Buy
256,305
+18,043
+8% +$359K 0.18% 50
2014
Q2
$4.58M Buy
238,262
+80,036
+51% +$1.49M 0.16% 52
2014
Q1
$2.97M Buy
158,226
+6,312
+4% +$122K 0.12% 68
2013
Q4
$2.96M Buy
151,914
+33,431
+28% +$613K 0.12% 66
2013
Q3
$1.95M Buy
118,483
+22,826
+24% +$366K 0.09% 73
2013
Q2
$1.43M Buy
+95,657
New +$1.4M 0.07% 76

Other funds holding IART

Snow Capital Management's IART Position: Q2 2021 in Review

Snow Capital Management sold out of Integra LifeSciences (IART) in Q2 2021, closing a stake of 11,816 shares — an estimated $816K sold.

Snow Capital Management first reported a position in IART in Q2 2013 and held it in 20 quarters. The position peaked at $20.3M in Q4 2015. 264 funds tracked by Wall St. Rank hold IART as of Q2 2021.

  • Snow Capital Management reported no remaining Integra LifeSciences position as of Q2 2021 after selling out during the quarter.
  • Snow Capital Management sold 11,816 Integra LifeSciences shares in Q2 2021, an estimated $816K.
  • Snow Capital Management first reported a position in Integra LifeSciences in Q2 2013 and held it in 20 quarters.
  • Snow Capital Management's Integra LifeSciences position peaked at $20.3M in Q4 2015.
  • 264 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2021.

Based on Snow Capital Management's 13F filing for Q2 2021, filed 12 Aug 2021.